Neurodegenerative Disease clinical trials at University of California Health
4 in progress, 2 open to eligible people
Brain Health Registry: An Online Registry to Identify and Assess Subjects for Brain Research
open to eligible people ages 18 years and up
The overall goal of this project is to identify, assess and longitudinally monitor subjects who are interested in participating in brain research. Participants will enroll through the website, BrainHealthRegistry.org, and provide informed consent prior to any study activities. The website will collect a variety of information, including participants' overall health, memory complaints, family history of dementia and Alzheimer's disease (AD), mood status, sleep, diet, and exercise-all through self-reported online questionnaires. Participants will also be ask to take online cognitive tests, and to return to the website at regular intervals, to complete follow-up questionnaires and neuropsychological assessments. Everyone over the age of 18 is welcome to participate. To join the Brain Health Registry, please visit www.BrainHealthRegistry.org.
at UCSF
FA Clinical Outcome Measures
open to eligible people ages 4-80
This multicenter natural history study aims to expand the network of clinical research centers in FA, and to provide a framework for facilitating therapeutic interventions. In addition, this study will lead to the development of valid yet sensitive clinical measures crucial to outcome assessment of patients with Friedreich's Ataxia. This study will support genetic modifier studies, biomarker studies, and frataxin protein level assessments by building a sample repository.
at UCLA
Clinical Utility of Pediatric Whole Exome Sequencing
Sorry, in progress, not accepting new patients
The investigator aims to examine the clinical utility of WES, including assessment of a variety of clinical outcomes in undiagnosed pediatric cases.
at UCSF
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Sorry, in progress, not accepting new patients
Safety and efficacy of AADC gene transfer in participants with Parkinson's disease.
at UCSF
Last updated: